<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Innovative fusion: MRSI-guided brain tumour classification via integrated image segmentation and GLCM feature extraction

dc.authorid0000-0003-4116-9673
dc.authorid0000-0002-6560-2403
dc.contributor.authorGhaffar, Ayesha
dc.contributor.authorJavid, Muhammad Arshad
dc.contributor.authorYaseen, Kiran
dc.contributor.authorAli, Nasir
dc.contributor.authorArshad, Shoaib
dc.contributor.authorEl-Bahkiry, Hesham S.
dc.contributor.authorAkgül, Ali
dc.date.accessioned2026-03-14T11:48:52Z
dc.date.available2026-03-14T11:48:52Z
dc.date.issued2025
dc.departmentSiirt Üniversitesi
dc.description.abstractAccurate brain tumour classification is crucial for effective diagnosis and treatment planning. This study aims to develop an advanced classification approach by integrating Magnetic Resonance Spectroscopy Imaging (MRSI) segmentation with Grey Level Co Occurrence Matrix (GLCM) feature extraction to improve glioma classification. Using MR images from 52 subjects, we examined various glioma metabolites and computed metabolite ratios within segmented tumour regions. GLCM features provided insights into pixel intensity spatial distributions and metabolic alterations, aiding in differentiation of tumour types and grades. Our method, employing image preprocessing, Otsu's thresholding for segmentation, and CNN Efficient Net for classification, achieved nearly 90% accuracy in high-grade glioma identification. The confusion matrix demonstrated strong classification performance, with a precision of 0.89 for healthy subjects and 0.92 for glioma cases, while recall values were 0.92 and 0.88, respectively. The F1-scores of 0.91 (healthy) and 0.90 (glioma) further indicate the model's balanced predictive capability. Additionally, the Receiver Operating Characteristic (ROC) curve yielded an AUC of 0.95, emphasising the effectiveness of the proposed approach. Significant correlations were found between model efficacy, metabolite ratios, and GLCM features, highlighting the efficiency of our method in brain tumour classification and its potential clinical relevance.
dc.identifier.doi10.1080/21681163.2025.2479707
dc.identifier.issn2168-1163
dc.identifier.issn2168-1171
dc.identifier.issue1
dc.identifier.scopus2-s2.0-105018457678
dc.identifier.scopusqualityQ2
dc.identifier.urihttps://doi.org/10.1080/21681163.2025.2479707
dc.identifier.urihttps://hdl.handle.net/20.500.12604/9000
dc.identifier.volume13
dc.identifier.wosWOS:001460472400001
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherTaylor & Francis Ltd
dc.relation.ispartofComputer Methods in Biomechanics and Biomedical Engineering-Imaging and Visualization
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20260310
dc.subjectConvolutional Neural Networks
dc.subjectMrsi
dc.subjectGliomas
dc.subjectGlcm
dc.subjectTumors
dc.subjectMagnetic Resonance Image
dc.subjectNeoplasm
dc.subjectBrain Tumour Classification
dc.subjectMedical Imaging
dc.titleInnovative fusion: MRSI-guided brain tumour classification via integrated image segmentation and GLCM feature extraction
dc.typeArticle

Dosyalar